Positive autoregulation of GDNF levels in the ventral tegmental area mediates long-lasting inhibition of excessive alcohol consumption

Translational Psychiatry

Volumn 1, Issue , 2011, Pages

  Barak, S ^a,b   Ahmadiantehrani, S ^a,c   Kharazia, V ^a   Ron, D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

addiction; alcohol; GDNF; growth factors; ventral tegmental area

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; MESSENGER RNA;

ALCOHOLISM; ANIMAL; ARTICLE; AUTOCRINE EFFECT; DRINKING BEHAVIOR; DRUG EFFECT; HOMEOSTASIS; LONG EVANS RAT; MALE; METABOLISM; PHYSIOLOGY; RAT; VENTRAL TEGMENTUM;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; AUTOCRINE COMMUNICATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HOMEOSTASIS; MALE; RATS; RATS, LONG-EVANS; RNA, MESSENGER; VENTRAL TEGMENTAL AREA;

EID: 83755170482     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2011.57     Document Type: Article

References (48)

1. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993; 260: 1130-1132. (Pubitemid 23186789)
2. Airaksinen MS, Saarma M. The GDNF family: Signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002; 3: 383-394. (Pubitemid 135706635)
3. Barroso-Chinea P, Cruz-Muros I, Aymerich MS, Rodriguez-Diaz M, Afonso-Oramas D, Lanciego JL et al. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells. Eur J Neurosci 2005; 21: 1815-1827. (Pubitemid 40685862)
4. Pochon NA, Menoud A, Tseng JL, Zurn AD, Aebischer P. Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization. Eur J Neurosci 1997; 9: 463-471. (Pubitemid 27144015)
5. Tomac A, Widenfalk J, Lin LF, Kohno T, Ebendal T, Hoffer BJ et al. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci USA 1995; 92: 8274-8278.
6. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson0s disease. Science 2000; 290: 767-773.
7. Wang J, Carnicella S, Ahmadiantehrani S, He DY, Barak S, Kharazia V et al. Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system. J Neurosci 2010; 30: 14502-14512.
8. Burazin TC, Gundlach AL. Localization of GDNF/neurturin receptor (c-ret, GFRalpha-1 and alpha-2) mRNAs in postnatal rat brain: Differential regional and temporal expression in hippocampus, cortex and cerebellum. Brain Res Mol Brain Res 1999; 73: 151-171.
9. Matsuo A, Nakamura S, Akiguchi I. Immunohistochemical localization of glial cell linederived neurotrophic factor family receptor alpha-1 in the rat brain: Confirmation of expression in various neuronal systems. Brain Res 2000; 859: 57-71. (Pubitemid 30138193)
10. Trupp M, Belluardo N, Funakoshi H, Ibanez CF. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J Neurosci 1997; 17: 3554-3567. (Pubitemid 27200583)
11. Sariola H, Saarma M. Novel functions and signalling pathways for GDNF. J Cell Sci 2003; 116(Part 19): 3855-3862. (Pubitemid 37279301)
12. Sherer TB, Fiske BK, Svendsen CN, Lang AE, Langston JW. Crossroads in GDNF therapy for Parkinson's disease. Mov Disord 2006; 21: 136-141.
13. Uchida S, Hara K, Kobayashi A, Otsuki K, Yamagata H, Hobara T et al. Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 2011; 69: 359-372.
14. Carnicella S, Ron D. GDNF-a potential target to treat addiction. Pharmacol Ther 2009; 122: 9-18.
15. Ghitza UE, Zhai H, Wu P, Airavaara M, Shaham Y, Lu L. Role of BDNF and GDNF in drug reward and relapse: A review. Neurosci Biobehav Rev 2009; 157-171.
16. Carnicella S, Amamoto R, Ron D. Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor. Alcohol 2009; 43: 35-43.
17. Carnicella S, Kharazia V, Jeanblanc J, Janak PH, Ron D. GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proc Natl Acad Sci USA 2008; 105: 8114-8119. (Pubitemid 351904717)
18. Barak S, Carnicella S, Yowell QV, Ron D. Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: Implications for alcohol reward and seeking. J Neurosci 2011; 31: 9885-9894.
19. He DY, Ron D. Autoregulation of glial cell line-derived neurotrophic factor expression: Implications for the long-lasting actions of the anti-addiction drug, Ibogaine. FASEB J 2006; 20: 2420-2422.
20. Golden JP, Baloh RH, Kotzbauer PT, Lampe PA, Osborne PA, Milbrandt J et al. Expression of neurturin, GDNF, and their receptors in the adult mouse CNS. J Comp Neurol 1998; 398: 139-150. (Pubitemid 28373881)
21. Glazner GW, Mu X, Springer JE. Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system. J Comp Neurol 1998; 391: 42-49. (Pubitemid 28109618)
22. Obrig TG, Culp WJ, McKeehan WL, Hardesty B. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J Biol Chem 1971; 246: 174-181.
23. Siegel MR, Sisler HD. Inhibition of protein synthesis in vitro by cycloheximide. Nature 1963; 200: 675-676.
24. Milekic MH, Brown SD, Castellini C, Alberini CM. Persistent disruption of an established morphine conditioned place preference. J Neurosci 2006; 26: 3010-3020.
25. National-Institute-on-Alcohol-Abuse-and-Alcoholism (NIAAA). Council approves definition of binge drinking. NIAAA Newsletter 2004; 3.
26. Carnicella S, Ahmadiantehrani S, He DY, Nielsen CK, Bartlett SE, Janak PH et al. Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor. Biol Psychiatry 2009; 66: 146-153.
27. He DY, McGough NN, Ravindranathan A, Jeanblanc J, Logrip ML, Phamluong K et al. Glial cell line-derived neurotrophic factor mediates the desirable actions of the antiaddiction drug ibogaine against alcohol consumption. J Neurosci 2005; 25: 619-628.
28. Xiong H, Futamura T, Jourdi H, Zhou H, Takei N, Diverse-Pierluissi M et al. Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons. Neuropharmacology 2002; 42: 903-912. (Pubitemid 34628621)
29. Patz S, Wahle P. Neurotrophins induce short-term and long-term changes of cortical neurotrophin expression. Eur J Neurosci 2004; 20: 701-708. (Pubitemid 39036930)
30. Canossa M, Griesbeck O, Berninger B, Campana G, Kolbeck R, Thoenen H. Neurotrophin release by neurotrophins: Implications for activity-dependent neuronal plasticity. Proc Natl Acad Sci USA 1997; 94: 13279-13286.
31. Righi M, Tongiorgi E, Cattaneo A. Brain-derived neurotrophic factor (BDNF) induces dendritic targeting of BDNF and tyrosine kinase B mRNAs in hippocampal neurons through a phosphatidylinositol-3 kinase-dependent pathway. J Neurosci 2000; 20: 3165-3174. (Pubitemid 30263133)
32. Jiao L, Zhang Y, Hu C, Wang YG, Huang A, He C. Rap1GAP interacts with RET and suppresses GDNF-induced neurite outgrowth. Cell Res 2011; 21: 327-337.
33. Tsui CC, Pierchala BA. CD2AP and Cbl-3/Cbl-c constitute a critical checkpoint in the regulation of ret signal transduction. J Neurosci 2008; 28: 8789-8800.
34. Vieira P, Thomas-Crusells J, Vieira A. Internalization of glial cell-derived neurotrophic factor receptor GFR alpha 1 in the absence of the ret tyrosine kinase coreceptor. Cell Mol Neurobiol 2003; 23: 43-55. (Pubitemid 36373674)
35. Ai Y, Markesbery W, Zhang Z, Grondin R, Elseberry D, Gerhardt GA et al. Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects. J Comp Neurol 2003; 461: 250-261. (Pubitemid 36583466)
36. Lapchak PA, Jiao S, Collins F, Miller PJ. Glial cell line-derived neurotrophic factor: Distribution and pharmacology in the rat following a bolus intraventricular injection. Brain Res 1997; 747: 92-102. (Pubitemid 27063803)
37. Mandel S, Grunblatt E, Maor G, Youdim MB. Early and late gene changes in MPTP mice model of Parkinson0s disease employing cDNA microarray. Neurochem Res 2002; 27: 1231-1243. (Pubitemid 35316119)
38. Yurek DM, Fletcher-Turner A. Temporal changes in the neurotrophic environment of the denervated striatum as determined by the survival and outgrowth of grafted fetal dopamine neurons. Brain Res 2002; 931: 126-134. (Pubitemid 34230516)
39. Grunblatt E, Mandel S, Maor G, Youdim MB. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine. J Neurochem 2001; 78: 1-12. (Pubitemid 32622583)
40. Yang F, Feng L, Zheng F, Johnson SW, Du J, Shen L et al. GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons. Nat Neurosci 2001; 4: 1071-1078. (Pubitemid 34116551)
41. Carnicella S, He DY, Yowell QV, Glick SD, Ron D. Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration. Addict Biol 2010; 15: 424-433.
42. Saavedra A, Baltazar G, Duarte EP. Driving GDNF expression: The green and the red traffic lights. Prog Neurobiol 2008; 86: 186-215.
43. Green-Sadan T, Kinor N, Roth-Deri I, Geffen-Aricha R, Schindler CJ, Yadid G. Transplantation of glial cell line-derived neurotrophic factor-expressing cells into the striatum and nucleus accumbens attenuates acquisition of cocaine self-administration in rats. Eur J Neurosci 2003; 18: 2093-2098. (Pubitemid 37372392)
44. Green-Sadan T, Kuttner Y, Lublin-Tennenbaum T, Kinor N, Boguslavsky Y, Margel S et al. Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats. Exp Neurol 2005; 194: 97-105. (Pubitemid 40723609)
45. Lu L, Wang X, Wu P, Xu C, Zhao M, Morales M et al. Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biol Psychiatry 2009; 66: 137-145.
46. Hong M, Mukhida K, Mendez I. GDNF therapy for Parkinson's disease. Expert Rev Neurother 2008; 8: 1125-1139. (Pubitemid 351962079)
47. Xia CF, Boado RJ, Zhang Y, Chu C, Pardridge WM. Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson0s disease with Trojan horse liposomes and a tyrosine hydroxylase promoter. J Gene Med 2008; 10: 306-315. (Pubitemid 351359643)
48. Manfredsson FP, Okun MS, Mandel RJ. Gene therapy for neurological disorders: Challenges and future prospects for the use of growth factors for the treatment of Parkinson0s disease. Curr Gene Ther 2009; 9: 375-388.